This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2022 May 5;386(18):1680-1682.

doi: 10.1056/NEJMp2200089. Epub 2022 Apr 30.

Real-World Evidence - Where Are We Now?

John Concato¹, Jacqueline Corrigan-Curay¹

Affiliations

Affiliation

¹ From the Office of Medical Policy (J.C.) and the Office of the Center Director (J.C.-C.), Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD; and Yale University, New Haven, CT (J.C.).

PMID: 35485775
DOI: 10.1056/NEJMp2200089

Real-World Evidence - Where Are We Now?

John Concato et al. N Engl J Med. 2022.

. 2022 May 5;386(18):1680-1682.

doi: 10.1056/NEJMp2200089. Epub 2022 Apr 30.

Authors

John Concato¹, Jacqueline Corrigan-Curay¹

Affiliation

¹ From the Office of Medical Policy (J.C.) and the Office of the Center Director (J.C.-C.), Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD; and Yale University, New Haven, CT (J.C.).

PMID: 35485775
DOI: 10.1056/NEJMp2200089

No abstract available

PubMed Disclaimer

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.